Linvoseltamab
Regeneron
['mmsm']
aa16: g1/2 crs 46%, g3:&lt;1%, ticino was used in 14% (low) , oxygen 3.4%, onset was 15 hrs, duration 17 hrs. no g4 #mmsm #myeloma #medtwitter #meded #asco23 #usmirc 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter